drugset / Trial / NCT07426068
Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation
Phase 0
Not yet recruiting
6 enrolled
National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Binhai Yangshi Orthopedic Hospital · collabNational Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Chinese PLA General Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
This study aims to apply autologous differentiated myocyte subcutaneous transplantation in patients with muscle atrophy to explore its safety, feasibility, and efficacy.
Timeline
- Start
- 2026-07-01
- Primary completion
- 2028-02-01
- Completion
- 2028-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous differentiated myocytes | Unknown | — | Subcutaneous |